Ras gene mutation is not related to tumour invasion during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide

Journal of Oral Pathology and Medicine

Volumn 40, Issue 4, 2011, Pages 325-333

  Fracalossi, Ana C C ^a   Comparini, Larissa ^a   Funabashi, Karina ^a   Godoy, Carla ^a   Iwamura, Edna S M ^a   Nascimento, Fábio D ^b   Nader, Helena B ^a   Oshima, Celina T F ^a   Ribeiro, Daniel A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Universidade Bandeirante de Sao Paulo   (Brazil)

Author keywords

4 nitroquinoline 1 oxide; Immunohistochemistry; Mutation in gene ras; Oral squamous cell carcinoma

Indexed keywords

4 NITROQUINOLINE 1 OXIDE; ALPHA SMOOTH MUSCLE ACTIN; DRINKING WATER; KI 67 ANTIGEN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INVASION; CARCINOGENESIS; CONTROLLED STUDY; DYSPLASIA; GENE MUTATION; HISTOPATHOLOGY; HYPERPLASIA; MALE; MOUTH MUCOSA; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SQUAMOUS CELL CARCINOMA; TONGUE CANCER;

4-NITROQUINOLINE-1-OXIDE; ACTINS; ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; GENES, RAS; KI-67 ANTIGEN; MALE; MUTATION; NEOPLASM INVASIVENESS; NEOPLASMS, EXPERIMENTAL; RAS PROTEINS; RATS; RATS, WISTAR; TONGUE NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79952844908     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2010.00987.x     Document Type: Article

References (43)

1. Myers JN, Elkins T, Roberts D, Byers RM. Squamous cell carcinoma of the tongue in young adults: increasing incidence and factors that predict treatment outcomes. Otolaryngol Head Neck Surg 2000; 122: 44-51.
2. Kantola S, Parikka M, Jokinen K, et al. Prognostic factors in tongue cancer - relative importance of demographic, clinical and histopathological factors. Br J Cancer 2000; 83: 614-9.
3. Okazaki Y, Tanaka Y, Tonogi M, Yamane G. Investigation of environmental factors for diagnosing malignant potential in oral epithelial dysplasia. Oral Oncol 2002; 38: 562-73.
4. Vered M, Daniel N, Hirshberg A, Dayan D. Histomorphologic and morphometric changes in minor salivary glands of the rat tongue during 4-nitroquinoline 1-oxide-induced carcinogenesis. Oral Oncol 2003; 39: 491-6.
5. Ribeiro DA, Salvadori DM, Marques ME. Abnormal expression of bcl-2 and bax in rat tongue mucosa during the development of squamous cell carcinoma induced by 4-nitroquinoline 1-oxide. Int J Exp Pathol 2005; 86: 375-81.
6. Niwa S, Ueno S, Shirasu R. Alteration of pRB expression in the development of rat tongue carcinoma induced by 4-nitroquinoline 1-oxide. Oral Oncol 2001; 37: 579-85.
7. Ribeiro DA, Kitakawa D, Domingues MA, Cabral LA, Marques ME, Salvadori DM. Survivin and nitric oxide inducible synthase production during 4NQO-induced rat tongue carcinogenesis, a possible relationship. Exp Mol Pathol 2007; 83: 131-7.
8. Silva RN, Ribeiro DA, Salvadori DM, Marques ME. Placental glutathione S-transferase correlates with cellular proliferation during rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide. Exp Toxicol Pathol 2007; 59: 61-8.
9. Ribeiro DA, Fracalossi AC, Uatari SA, Oshima CT, Salvadori DM. Imbalance of tumor suppression genes expression following rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide. In Vivo 2009; 23: 937-42.
10. Fracalossi AC, Silva MD, Oshima CT, Ribeiro DA. Wnt/beta-catenin signalling pathway following rat tongue carcinogenesis induced by 4-nitroquinoline 1-oxide. Exp Mol Pathol 2010; 88: 176-83.
11. Naoi K, Sunagawa N, Yoshida I, et al. Enhancement of tongue carcinogenesis in Hras128 transgenic rats treated with 4-nitroquinoline 1-oxide. Oncol Rep 2010; 23: 337-44.
12. Chang YS, Yeh KT, Hsu NC, Lin SH, Chang TJ, Chang JG. Detection of N-, H-, and KRAS codons 12, 13, and 61 mutations with universal RAS primer multiplex PCR and N-, H-, and KRAS-specific primer extension. Clin Biochem 2010; 43: 296-301.
13. Bos JL. Ras oncogenes in human cancer: a review. Cancer Res 1989; 49: 4682-9.
14. van Diest PJ, Brugal G, Baak JP. Proliferation markers in tumours: interpretation and clinical value. J Clin Pathol 1998; 51: 716-24.
15. Xie X, De Angelis P, Clausen OP, Boysen M. Prognostic significance of proliferative and apoptotic markers in oral tongue squamous cell carcinomas. Oral Oncol 1999; 35: 502-9.
16. Pich A, Chiusa L, Navone R. Prognostic relevance of cell proliferation in head and neck tumors. Ann Oncol 2004; 15: 319-29.
17. Lothaire P, de Azambuja E, Dequanter D, et al. Molecular markers of head and necksquamous cell carcinoma: promising signs in need of prospective evaluation. Head Neck 2006; 28: 256-69.
18. Kim SJ, Shin HJ, Jung KY, et al. Prognostic value of carbonic anhydrase IX and Ki-67 expression in squamous cell carcinoma of the tongue. Jpn J Clin Oncol 2007; 37: 812-9.
19. Wangsa D, Ryott M, Avall-Lundqvist E, et al. Ki-67 expression predicts locoregional recurrence in stage I oral tongue carcinoma. Br J Cancer 2008; 99: 1121-8.
20. Angiero F, Berenzi A, Benetti A, et al. Expression of p16, p53 and Ki-67 proteins in the progression of epithelial dysplasia of the oral cavity. Anticancer Res 2008; 28: 2535-9.
21. Tomasek JJ, Gabbiani G, Hinz B, Chaponnien C, Brown RA. Myofibroblasts and mechano-regulation of connective tissue remodeling. Nat Rev Mol Cell Biol 2002; 3: 349-63.
22. Chen Y, Satoh T, Sasatomi E, Miyazaki K, Tokunaga O. Critical role of type IV collagens in the growth of bile duct carcinoma. Pathol Res Pract 2001; 197: 585-96.
23. Lewis MP, Lygoe KA, Nystrom ML, et al. Tumor-derived TGF-b1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells. Br J Cancer 2004; 90: 822-32.
24. Rousseau B, Larrieu-Lahargue F, Javerzat S, Guilhem-Ducleon F, Beermann F, Bikfalvi A. The tryp1-Tag/tryp1-FGFR-DN biogenic mouse: a model for selective inhibition of tumor development, angiogenesis, and invasion into the neural tissue by blocking fibroblast growth factor receptor activity. Cancer Res 2004; 64: 2490-5.
25. Vered M, Allon I, Buchner A, Dayan D. Stromal myofibroblasts and malignant transformation in a 4NQO rat tongue carcinogenesis model. Oral Oncol 2007; 43: 999-1006.
26. Etemad-Moghadam S, Khalili M, Tirgary F, Alaeddini M. Evaluation of myofibroblasts in oral epithelial dysplasia and squamous cell carcinoma. J Oral Pathol Med 2009; 38: 639-43.
27. Badiglian Filho L, Oshima CT, De Oliveira Lima F, et al. Canonical and noncanonical Wnt pathway: a comparison among normal ovary, benign ovarian tumor and ovarian cancer. Oncol Rep 2009; 21: 313-20.
28. Shah NG, Trivedi TI, Tankshali RA, et al. Molecular alterations in oral carcinogenesis, significant risk predictors in malignant transformation and tumor progression. Int J Biol Markers 2007; 22: 132-43.
29. Herzig M, Christofori G. Recent advances in cancer research, mouse models of tumorigenesis. Biochim Biophys Acta 2002; 1602: 97-113.
30. Hayashi S, Nonoyama T, Miyajima H. Spontaneous nonthymic cell lymphomas in young Wistar rats. Vet Pathol 1989; 26: 326-32.
31. Minamoto T, Mai M, Ronai Z. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers - a review. Cancer Detect Prev 2000; 24: 1-12.
32. Hoellering J, Shuler CF. Localization of H-ras mRNA in oral squamous cell carcinomas. J Oral Pathol Med 1989; 18: 74-8.
33. Suzui M, Yoshimi N, Tanaka T, Mori H. Infrequent Ha-ras mutations and absence of Ki-ras, N-ras, and p53 mutations in 4-nitroquinoline 1-oxide-induced rat oral lesions. Mol Carcinog 1995; 14: 294-8.
34. Nakahara Y, Shintani S, Mihara M, Matsumura T, Hamakawa H. High frequency methylation of p16INK4A gene during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Oncol Rep 2004; 12: 101-6.
35. Ogawa K, Tanuma J, Hirano M, et al. Selective loss of resistant alleles at p15INK4B and p16INK4A genes in chemically-induced rat tongue cancers. Oral Oncol 2006; 42: 710-7.
36. Fuentes-Calvo I, Blázquez-Medela AM, Santos E, López-Novoa JM, Martínez-Salgado C. Analysis of k-ras nuclear expression in fibroblasts and mesangial cells. PLoS ONE 2010; 5: e8703.
37. Birchenall-Roberts MC, Fu T, Kim SG, et al. K-Ras4B proteins are expressed in the nucleolus: interaction with nucleolin. Biochem Biophys Res Commun 2006; 348: 540-9.
38. Wurzer G, Mosgoeller W, Chabicovsky M, Cerni C, Wesierska-Gadek J. Nuclear Ras: unexpected subcellular distribution of oncogenic forms. J Cell Biochem 2001; 81: 1-11.
39. Tubiana M, Courdi A. Cell proliferation kinetics in human solid tumors: relation to probability of metastatic dissemination and long-term survival. Radiother Oncol 1989; 15: 1-18.
40. Wilkey JF, Buchberger G, Saucier K, et al. Cyclin D1 overexpression increases susceptibility to 4-nitroquinoline-1-oxide-induced dysplasia and neoplasia in murine squamous oral epithelium. Mol Carcinog 2009; 48: 853-61.
41. Desmouliere A, Guyot C, Gabbiani G. The stroma reaction myofibroblasts: a key player in the control of tumor behavior. Int J Dev Biol 2004; 48: 509-17.
42. De Wever O, Mareel M. Role of tissue stroma in cancer cell invasion. J Pathol 2003; 200: 429-47.
43. Mǎrgǎritescu C, Pirici D, Simionescu C, et al. VEGF and VEGFRs expression in oral squamous cell carcinoma. Rom J Morphol Embryol 2009; 50: 527-48.